Biweekly Docetaxel in Patients With Metastatic Breast Cancer.
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Docetaxel
Sponsor: Centro Universitario contra el Cáncer